Understanding HBOT Costs
HBOT cost in the US splits sharply by indication status. For the 14 UHMS-approved indications treated at UHMS-accredited hospital facilities, CMS/Medicare and most private insurers cover HBOT — typical reimbursement is approximately $450 per session, with the patient responsible only for applicable co-pays, deductibles, or coinsurance. For off-label indications (TBI, long COVID, stroke recovery, fibromyalgia, anti-ageing, autism, PTSD, sports recovery), HBOT is almost always paid out of pocket.
Private Clinic Cash-Pay Pricing
Private hyperbaric clinics in the US typically charge $150–$450 per session for off-label HBOT, with regional variation. Major metros (NYC, LA, SF, Boston) tend toward the higher end; smaller markets toward the lower end. A full 40-session neurological course therefore runs approximately $6,000–$18,000 in direct session costs, plus any travel, lodging, and ancillary medical costs.
Home Chamber Capital Cost
Soft-shell home chambers at 1.3 ATA have a one-time capital cost of $5,000–$20,000 depending on size and manufacturer. Compact hard-shell home units at 1.5–2.0 ATA cost $30,000–$100,000+. For users running extended protocols (3–6 months of daily sessions), home ownership can be more economical than cash-pay clinical sessions over 1–2 years — though the evidence at 1.3 ATA is weaker than at clinical pressures.
Hidden and Ancillary Costs
- Pre-treatment evaluation: Hyperbaric physician consultation, chest imaging, ear equalisation assessment ($500–$2,000).
- Baseline testing: Neurocognitive batteries, imaging (SPECT, perfusion MRI) for neurological protocols ($1,000–$5,000+).
- Travel and lodging: For patients travelling to specialised centres (Efrati-affiliated clinics, major US hyperbaric programmes), weekly accommodation can double or triple the direct session cost.
- Lost income: 90-minute daily sessions for 8 weeks can substantially affect work capacity.
- Follow-up assessment: Post-course cognitive and functional measures ($500–$2,000).
Insurance Appeals
When CMS or private insurers deny coverage, appeals are possible but difficult. First-level appeals have the highest success rate when the indication is UHMS-approved and the denial is based on documentation issues (fixable). Off-label indication denials are rarely successfully appealed through standard insurance pathways. Some state-level programmes (Oklahoma, Texas, Florida) provide specific HBOT access for veterans with TBI.
International Options
Some patients travel internationally for HBOT access. Mexican border clinics offer off-label HBOT at lower per-session cost than US private clinics. Israel's Efrati-affiliated centres are a destination for off-label neurological HBOT. Several European countries have more comprehensive national health system coverage for HBOT than the US. International travel adds significant logistical cost and complexity.
Research disclaimer: Cost estimates are approximations based on US market reporting at the time of writing. Actual costs vary significantly by facility, insurance plan, geographic location, and over time. Verify specific pricing directly with the facility and your insurance plan before committing to a course.